AAPL   318.68 (+0.14%)
MSFT   181.19 (-0.12%)
FB   224.68 (-0.35%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,409.47 (+0.35%)
NVDA   342.91 (+1.01%)
CGC   17.59 (-19.02%)
BABA   198.52 (-0.49%)
MU   46.66 (+0.41%)
GE   6.51 (-3.98%)
TSLA   817.27 (+1.42%)
AMD   52.23 (+0.95%)
T   30.61 (-1.45%)
ACB   14.04 (-8.47%)
F   5.64 (-3.59%)
GILD   75.05 (-0.36%)
DIS   114.49 (-1.94%)
NFLX   413.30 (-0.03%)
BAC   24.40 (-1.85%)
BA   144.04 (-3.86%)
AAPL   318.68 (+0.14%)
MSFT   181.19 (-0.12%)
FB   224.68 (-0.35%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,409.47 (+0.35%)
NVDA   342.91 (+1.01%)
CGC   17.59 (-19.02%)
BABA   198.52 (-0.49%)
MU   46.66 (+0.41%)
GE   6.51 (-3.98%)
TSLA   817.27 (+1.42%)
AMD   52.23 (+0.95%)
T   30.61 (-1.45%)
ACB   14.04 (-8.47%)
F   5.64 (-3.59%)
GILD   75.05 (-0.36%)
DIS   114.49 (-1.94%)
NFLX   413.30 (-0.03%)
BAC   24.40 (-1.85%)
BA   144.04 (-3.86%)
AAPL   318.68 (+0.14%)
MSFT   181.19 (-0.12%)
FB   224.68 (-0.35%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,409.47 (+0.35%)
NVDA   342.91 (+1.01%)
CGC   17.59 (-19.02%)
BABA   198.52 (-0.49%)
MU   46.66 (+0.41%)
GE   6.51 (-3.98%)
TSLA   817.27 (+1.42%)
AMD   52.23 (+0.95%)
T   30.61 (-1.45%)
ACB   14.04 (-8.47%)
F   5.64 (-3.59%)
GILD   75.05 (-0.36%)
DIS   114.49 (-1.94%)
NFLX   413.30 (-0.03%)
BAC   24.40 (-1.85%)
BA   144.04 (-3.86%)
AAPL   318.68 (+0.14%)
MSFT   181.19 (-0.12%)
FB   224.68 (-0.35%)
GOOGL   1,422.61 (+0.31%)
AMZN   2,409.47 (+0.35%)
NVDA   342.91 (+1.01%)
CGC   17.59 (-19.02%)
BABA   198.52 (-0.49%)
MU   46.66 (+0.41%)
GE   6.51 (-3.98%)
TSLA   817.27 (+1.42%)
AMD   52.23 (+0.95%)
T   30.61 (-1.45%)
ACB   14.04 (-8.47%)
F   5.64 (-3.59%)
GILD   75.05 (-0.36%)
DIS   114.49 (-1.94%)
NFLX   413.30 (-0.03%)
BAC   24.40 (-1.85%)
BA   144.04 (-3.86%)
Log in

ASX:VLSVita Life Sciences Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,815 shs
Average VolumeN/A
Market Capitalization$38.44 million
P/E Ratio15.80
Dividend Yield8.33%
BetaN/A
Vita Life Sciences Limited, a pharmaceutical and healthcare company, engages in formulation, packaging, sale, and distribution of vitamins and supplements. It offers a range of supplements, vitamins, minerals, herbs, and superfoods. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold, VitaScience, and VitaLife brand names. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, Hong Kong, and China. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9828 0500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.45 million
Book ValueA$0.41 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$38.44 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VLS News and Ratings via Email

Sign-up to receive the latest news and ratings for VLS and its competitors with MarketBeat's FREE daily newsletter.

Vita Life Sciences (ASX:VLS) Frequently Asked Questions

How often does Vita Life Sciences pay dividends? What is the dividend yield for Vita Life Sciences?

Vita Life Sciences announced a Final dividend on Friday, February 21st. Stockholders of record on Friday, April 3rd will be paid a dividend of 0.023 per share on Friday, April 3rd. This represents a dividend yield of 3.46%. The ex-dividend date is Thursday, March 19th. View Vita Life Sciences' dividend history.

Has Vita Life Sciences been receiving favorable news coverage?

Press coverage about VLS stock has been trending somewhat negative this week, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vita Life Sciences earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutVita Life Sciences.

Who are some of Vita Life Sciences' key competitors?

Who are Vita Life Sciences' key executives?

Vita Life Sciences' management team includes the following people:
  • Mr. Andrew O'Keefe, MD & Director
  • Mr. Chin Leng Khoo, CFO & Company Sec.
  • Ms. Melissa Pereira, Head of Marketing
  • Mr. Edward Choop, Chief Exec. Officer of Asia Pacific
  • K. S. Beh, Head of Operations for Asia Pacific

What is Vita Life Sciences' stock symbol?

Vita Life Sciences trades on the ASX under the ticker symbol "VLS."

How big of a company is Vita Life Sciences?

Vita Life Sciences has a market capitalization of $0.00 and generates $42.45 million in revenue each year.

What is Vita Life Sciences' official website?

The official website for Vita Life Sciences is www.vitalifesciences.com.

How can I contact Vita Life Sciences?

The company can be reached via phone at 61 3 9828 0500.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.